Drug Trial Radar · NCT06961968
Randomized Withdrawal Study in Patients With Schizophrenia
Last checked: Nov 20, 2026Latest source record: Jan 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
400
Planned (sponsor's estimate)
Start
May 14, 2025
Primary completion
Nov 2027
Study completion Nov 2027
Sponsor
- Lead sponsor
- Vanda PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- May 8, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this research is to evaluate the efficacy of dosing iloperidone long-acting injection (LAI) compared to placebo in preventing the exacerbation of symptoms in patients with schizophrenia.
Conditions
- Schizophrenia
Interventions
iloperidoneDrug
iloperidone LAI
placeboDrug
matching placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to exacerbation of symptomsTime frame: Up to 52 weeks post-randomization
Locations
22 sites in 1 country. Site status is shown where the registry gives one.
Vanda Investigational Site
Rogers, Arkansas · Recruiting
Vanda Investigational Site
Costa Mesa, California · Recruiting
Vanda Investigational Site
Lemon Grove, California · Recruiting
Vanda Investigational Site
Oceanside, California · Recruiting
Vanda Investigational Site
Pico Rivera, California · Recruiting
Vanda Investigational Site
San Diego, California · Recruiting
Vanda Investigational Site
Walnut Creek, California · Recruiting
Vanda Investigational Site
North Miami, Florida · Recruiting
Vanda Investigational Site
Atlanta, Georgia · Recruiting
Vanda Investigational Site
Peachtree Corners, Georgia · Recruiting
Vanda Investigational Site
Chicago, Illinois · Recruiting
Vanda Investigational Site
Flowood, Mississippi · Recruiting
Vanda Investigational Site
Saint Charles, Missouri · Recruiting
Vanda Investigational Site
St Louis, Missouri · Recruiting
Vanda Investigational Site
Las Vegas, Nevada · Recruiting
Vanda Investigational Site
Marlton, New Jersey · Recruiting
Vanda Investigational Site
Staten Island, New York · Recruiting
Vanda Investigational Site
Austin, Texas · Recruiting
Vanda Investigational Site
Houston, Texas · Recruiting
Vanda Investigational Site
Irving, Texas · Recruiting
Vanda Investigational Site
Richardson, Texas · Recruiting
Vanda Investigational Site
Bellevue, Washington · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.